Broad Humoral and Cellular Immunity Elicited by a Bivalent DNA Vaccine Encoding HA and NP Genes from an H5N1 Virus
Open Access
- 1 February 2011
- journal article
- research article
- Published by SAGE Publications in Viral Immunology
- Vol. 24 (1) , 45-56
Abstract
Influenza A virus is highly variable and a major viral respiratory pathogen that can cause severe illness in humans. Therefore it is important to induce a sufficient immune response specific to current strains and to heterosubtypic viruses with vaccines. In this study, we developed a dual-promoter-based bivalent DNA vaccine that encodes both hemagglutinin (HA) and nucleoprotein (NP) proteins from a highly pathogenic A/Chicken/Henan/12/2004 (H5N1) virus. Our results show that the expression levels of HA and NP genes from the dual-promoter plasmid are similar to those seen when they are expressed individually in independent plasmids. When the bivalent DNA vaccine was inoculated via intramuscular injection and in vivo electroporation, high levels of both humoral and cellular immune responses were elicited against homologous H5N1 virus and heterosubtypic H9N2 virus. Furthermore, no obvious antigenic competition was observed between HA and NP proteins in the dual-promoter-based bivalent vaccine compared to monovalent vaccines. Our data suggest that a combination of influenza surface and internal viral genes in a dual-promoter-expressing plasmid may provide a new approach for developing a DNA vaccine that may protect not only specifically against a currently circulating strain, but also may cross-protect broadly against new heterosubtypic viruses.Keywords
This publication has 59 references indexed in Scilit:
- Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in HumansScience, 2009
- Pandemic Potential of a Strain of Influenza A (H1N1): Early FindingsScience, 2009
- A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in miceBMC Infectious Diseases, 2009
- Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibodyVirology, 2009
- A consensus–hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza virusesProceedings of the National Academy of Sciences, 2008
- Immunization by Avian H5 Influenza Hemagglutinin Mutants with Altered Receptor Binding SpecificityScience, 2007
- Prospects for Universal Influenza Virus VaccineEmerging Infectious Diseases, 2006
- Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in miceBiochemical and Biophysical Research Communications, 2005
- In vivo electroporation improves immune responses to DNA vaccination in sheepVaccine, 2004
- Characterization and Immunological Properties of Influenza A Virus Nucleoprotein (NP): Cell-associated NP Isolated from Infected Cells or Viral NP Expressed by Vaccinia Recombinant Virus do not Confer ProtectionJournal of General Virology, 1990